Translation, Cross-Cultural Adaptation, and Psychometric Properties of the Revised Fibromyalgia Impact Questionnaire (FIQR) for Use in Arabic-Speaking Patients in Saudi Arabia

References

• Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547–1555. doi:10.1001/jama.2014.3266
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles M, et al. The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–610. doi:10.1002/acr.20140
   PubMed Web of Science ®Google Scholar
• Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356. doi:10.1007/s11916-013-0356-5
   PubMed Web of Science ®Google Scholar
• Bawazir Y. Prevalence of fibromyalgia syndrome in Saudi Arabia: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2023;24(1):692. doi:10.1186/s12891-023-06821-z
   PubMed Web of Science ®Google Scholar
• Grodman I, Buskila D, Arnson Y, Altaman A, Amital D, Amital H. Understanding fibromyalgia and its resultant disability. Isr Med Assoc J. 2011;13(12):769–772.
   PubMed Web of Science ®Google Scholar
• White LA, Birnbaum HG, Kaltenboeck A, Tang J, Mallett D, Robinson RL. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med. 2008;50(1):13–24. doi:10.1097/JOM.0b013e31815cff4b
   PubMed Web of Science ®Google Scholar
• D’Onghia M, Ciaffi J, Ruscitti P, et al. The economic burden of fibromyalgia: a systematic literature review. Semin Arthritis Rheumatism. 2022;56:152060. doi:10.1016/j.semarthrit.2022.152060.
   PubMed Web of Science ®Google Scholar
• Hughes G, Martinez C, Myon E, Taïeb C, Wessely S. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheumatol. 2006;54(1):177–183. doi:10.1002/art.21545
   PubMedGoogle Scholar
• Salaffi F, Sarzi-Puttini P, Girolimetti R, Atzeni F, Gasparini S, Grassi W. Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol. 2009;27(5 Suppl 56):1.
   Web of Science ®Google Scholar
• Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991;18(5):728–733.
   PubMed Web of Science ®Google Scholar
• Mease P, Arnold LM, Choy EH, et al. Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol. 2009;36(10):2318–2329. doi:10.3899/jrheum.090367
   PubMed Web of Science ®Google Scholar
• Döhmen A, Kock M, Fischer F, Rose M, Obbarius A, Klapproth CP. Are OMERACT recommendations followed in clinical trials on fibromyalgia? A systematic review of patient-reported outcomes and their measures. Qual Life Res. 2023;32(6):1521–1536. doi:10.1007/s11136-022-03261-5
   PubMed Web of Science ®Google Scholar
• Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):1–14. doi:10.1186/ar2830
   Web of Science ®Google Scholar
• Salgueiro M, García-Leiva JM, Ballesteros J, Hidalgo J, Molina R, Calandre EP. Validation of a Spanish version of the revised fibromyalgia impact questionnaire (FIQR). Health Qual Life Outcomes. 2013;11(1):1–8. doi:10.1186/1477-7525-11-132
   PubMedGoogle Scholar
• Li Y, Jiang Q, Jia Y, et al. A Chinese version of the revised fibromyalgia impact questionnaire: a validation study. Int J Rheum Dis. 2023;26(2):242–249. doi:10.1111/1756-185X.14472
   PubMed Web of Science ®Google Scholar
• Ediz L, Hiz O, Toprak M, Tekeoglu I, Ercan S. The validity and reliability of the Turkish version of the revised fibromyalgia impact questionnaire. Clin Rheumatol. 2011;30(3):339–346. doi:10.1007/s10067-010-1546-8
   PubMed Web of Science ®Google Scholar
• Srifi N, Bahiri R, Rostom S, Bendeddouche I, Lazrek N, Hajjaj-Hassouni N. The validity and reliability of the Moroccan version of the revised fibromyalgia impact questionnaire. Rheumatol Int. 2013;33(1):179–183. doi:10.1007/s00296-011-2331-y
   PubMed Web of Science ®Google Scholar
• Salaffi F, Franchignoni F, Giordano A, Ciapetti A, Sarzi-Puttini P, Ottonello M. Psychometric characteristics of the Italian version of the revised fibromyalgia impact questionnaire using classical test theory and rasch analysis. Clin Exp Rheumatol. 2013;31(Suppl 79):1.
   PubMedGoogle Scholar
• Salgueiro Macho M, García Leiva J, Ballesteros Rodríguez FJ, Molina R, Calandre EP. Validation of a Spanish version of the revised Fibromyalgia Impact Questionnaire (FIQR). Health Qual Life Outcomes. 2013;11:1–8. doi:10.1186/1477-7525-11-1
   PubMed Web of Science ®Google Scholar
• Althobaiti NK, Amin BA, Alhamyani AD, et al. Prevalence of fibromyalgia syndrome in Taif City, Saudi Arabia. Cureus. 2022;14(12):1.
   Web of Science ®Google Scholar
• Gagnier JJ, Lai J, Mokkink LB, Terwee CB. COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures. Qual Life Res. 2021;30(8):2197–2218. doi:10.1007/s11136-021-02822-4
   PubMed Web of Science ®Google Scholar
• Acquadro C, Conway K, Giroudet C, Mear I. Linguistic validation manual for patient-reported outcomes (PRO) instruments. Lyon. 2004;1:184.
   Google Scholar
• Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186–3191. doi:10.1097/00007632-200012150-00014
   PubMed Web of Science ®Google Scholar
• Association WM. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194.
   PubMed Web of Science ®Google Scholar
• AlAujan SS, Almalag HM, Assiri GA, Alodaibi FA, Omair MA. Fibromyalgia Rapid Screening Tool (FiRST): Arabic translation and cross-cultural adaptation and validation. Health. 2023;11(7):1.
   Google Scholar
• Carlson ED. A case study in translation methodology using the health‐promotion lifestyle profile II. Public Health Nurs. 2000;17(1):61–70. doi:10.1046/j.1525-1446.2000.00061.x
   PubMed Web of Science ®Google Scholar
• Corp IBM. IBM SPSS Statistics for Windows, Version 27.0. NY: Armonk; IBM Corp.; 2020.
   Google Scholar
• Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737–745. doi:10.1016/j.jclinepi.2010.02.006
   PubMed Web of Science ®Google Scholar
• El-Naby M, Hefny M, Fahim A, Awadalla M. Validation of an adapted Arabic version of fibromyalgia syndrome impact questionnaire. Rheumatol Int. 2013;33(10):2561–2567. doi:10.1007/s00296-013-2779-z
   PubMed Web of Science ®Google Scholar
• Srifi N, Bahiri R, Rostom S, Bendeddouche I, Lazrek N, Hajjaj-Hassouni N. The validity and reliability of the Moroccan version of the revised fibromyalgia impact questionnaire. Rheumatol Int. 2012;33. doi:10.1007/s00296-010-1571-6
   PubMed Web of Science ®Google Scholar
• Abu-Dahab S, Aburuz S, Mustafa K, Sarhan Y. Validation of the Arabic version of the revised Fibromyalgia Impact Questionnaire (FIQR_A) on Jordanian females with fibromyalgia. Clin Rheumatol. 2013;33. doi:10.1007/s10067-012-2086-1
   PubMed Web of Science ®Google Scholar
• Gerlach P, Eriksson K. Measuring cultural dimensions: external validity and internal consistency of Hofstede’s VSM 2013 Scales. Front Psychol. 2021;12:662604. doi:10.3389/fpsyg.2021.662604
   PubMed Web of Science ®Google Scholar
• Siedlecki KL, Falzarano F, Salthouse TA. Examining gender differences in neurocognitive functioning across adulthood. J Int Neuropsychol Soc. 2019;25(10):1051–1060. doi:10.1017/S1355617719000821
   PubMed Web of Science ®Google Scholar
• Moschis GP, Ong FS, Abessi M, Yamashita T, Mathur A. Cultural and age-related differences in reliability: an empirical study in the United States, Japan and Malaysia. J Target Meas Anal Market. 2011;19(3–4:1.
   Google Scholar
• Alodaibi F, Alhowimel A, Alotaibi M, Alimam D, Fritz J. Knowledge, awareness, and perceptions of the diagnosis and management of fibromyalgia among physical therapists in Saudi Arabia: a cross-sectional survey. Open Access Rheumatol. 2020;12:293–301. doi:10.2147/OARRR.S284555
   PubMedGoogle Scholar
• Cardenas-Rojas A, Pacheco-Barrios K, Castelo-Branco L, et al. Barriers and facilitators for clinical trial participation of underrepresented and non-underrepresented fibromyalgia patients: a cross-sectional internet survey. Heliyon. 2021;7:e07475.
   PubMed Web of Science ®Google Scholar
• Qureshi A, Jha S, Iskander J, et al. Diagnostic challenges and management of fibromyalgia. Cureus. 2021;1:13.
   Google Scholar
• Kotronoulas G, Kearney N, Maguire R, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. 2014;32(14):1480–1510. doi:10.1200/JCO.2013.53.5948
   PubMed Web of Science ®Google Scholar
• Boyce MB, Browne JP. Does providing feedback on patient-reported outcomes to healthcare professionals result in better outcomes for patients? A systematic review. Qual Life Res. 2013;22(9):2265–2278. doi:10.1007/s11136-013-0390-0
   PubMed Web of Science ®Google Scholar
• Squitieri L, Bozic KJ, Pusic AL. The role of patient-reported outcome measures in value-based payment reform. Value Health. 2017;20(6):834–836. doi:10.1016/j.jval.2017.02.003
   PubMed Web of Science ®Google Scholar
• Snyder CF, Jensen RE, Segal JB, Wu AW. Patient-reported outcomes (PROs): putting the patient perspective in patient-centered outcomes research. Med Care. 2013;1:51:S73–79.
   Google Scholar
• Alaqeel S, Alfakhri A, Alkherb Z, Almeshal N. Patient-reported outcome measures in Arabic-speaking populations: a systematic review. Qual Life Res. 2022;31:1–12.
   Google Scholar